BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu W, Wu C, Wang Y, Hung H, Yang H, Kao W, Su C, Wu J, Chan W, Lin H, Lee F, Lee S. Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects. Aliment Pharmacol Ther 2012;36:560-8. [DOI: 10.1111/j.1365-2036.2012.05224.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Janičko M, Veselíny E, Orenčák R, Husťak R, Fedačko J, Dražilová S, Madarasová-gecková A, Mareková M, Pella D, Kristián P, Rác M, Jarčuška P. Redefining the alanine aminotransferase upper limit of normal improves the prediction of metabolic syndrome risk. European Journal of Gastroenterology & Hepatology 2015;27:405-11. [DOI: 10.1097/meg.0000000000000297] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Martin-Rodriguez JL, Gonzalez-Cantero J, Gonzalez-Cantero A, Arrebola JP, Gonzalez-Calvin JL. Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy. Medicine (Baltimore). 2017;96:e6770. [PMID: 28445310 DOI: 10.1097/md.0000000000006770] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
3 Cheng Y, Wang Y, Lan K, Huo T, Huang Y, Su C, Lin H, Lee F, Wu J, Lee S. Anti-hepatitis C virus seropositivity is not associated with metabolic syndrome irrespective of age, gender and fibrosis. Annals of Hepatology 2015;14:181-9. [DOI: 10.1016/s1665-2681(19)30780-x] [Cited by in Crossref: 15] [Article Influence: 2.1] [Reference Citation Analysis]
4 Vespasiani-Gentilucci U, De Vincentis A, Ferrucci L, Bandinelli S, Antonelli Incalzi R, Picardi A. Low Alanine Aminotransferase Levels in the Elderly Population: Frailty, Disability, Sarcopenia, and Reduced Survival. J Gerontol A Biol Sci Med Sci 2018;73:925-30. [PMID: 28633440 DOI: 10.1093/gerona/glx126] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
5 Huang DQ, Yeo YH, Tan E, Takahashi H, Yasuda S, Saruwatari J, Tanaka K, Oniki K, Kam LY, Muthiah MD, Hyogo H, Ono M, Barnett SD, Li J, Zou B, Fung J, Lee TY, Wong VW, Yuen MF, Dan YY, Lim SG, Cheung R, Toyoda H, Eguchi Y, Nguyen MH. ALT Levels for Asians With Metabolic Diseases: A Meta-analysis of 86 Studies With Individual Patient Data Validation. Hepatol Commun 2020;4:1624-36. [PMID: 33163833 DOI: 10.1002/hep4.1593] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Woo Baidal JA, Lavine JE. The intersection of nonalcoholic fatty liver disease and obesity. Sci Transl Med 2016;8:323rv1. [PMID: 26819197 DOI: 10.1126/scitranslmed.aad8390] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
7 Salawi HA, Ambler KA, Padwal RS, Mager DR, Chan CB, Ball GD. Characterizing severe obesity in children and youth referred for weight management. BMC Pediatr 2014;14:154. [PMID: 24947311 DOI: 10.1186/1471-2431-14-154] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
8 You SC, Kim KJ, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Lee WJ, Han KH. Factors associated with significant liver fibrosis assessed using transient elastography in general population. World J Gastroenterol 2015; 21(4): 1158-1166 [PMID: 25632188 DOI: 10.3748/wjg.v21.i4.1158] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
9 Tomizawa M, Kawanabe Y, Shinozaki F, Sato S, Motoyoshi Y, Sugiyama T, Yamamoto S, Sueishi M. Elevated levels of alanine transaminase and triglycerides within normal limits are associated with fatty liver. Exp Ther Med 2014;8:759-62. [PMID: 25120595 DOI: 10.3892/etm.2014.1798] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wu P, Chen Q, Chen L, Zhang P, Xiao J, Chen X, Liu M, Wang S. Dose-Response Relationship between Alanine Aminotransferase Levels within the Reference Interval and Metabolic Syndrome in Chinese Adults. Yonsei Med J 2017;58:158-64. [PMID: 27873509 DOI: 10.3349/ymj.2017.58.1.158] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
11 Liu Z, Que S, Xu J, Peng T. Alanine aminotransferase-old biomarker and new concept: a review. Int J Med Sci 2014;11:925-35. [PMID: 25013373 DOI: 10.7150/ijms.8951] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 9.6] [Reference Citation Analysis]
12 Puigvehí M, De Cuenca B, Viu A, Diago M, Turnes J, Gea F, Pascasio JM, Lens S, Cabezas J, Badia E, Olveira A, Morillas RM, Torras X, Montoliu S, Cordero P, Castro JL, Salmerón J, Molina E, Sánchez-Ruano JJ, Moreno J, Antón MD, Moreno JM, De la Vega J, Calleja JL, Carrión JA. Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort. Liver Int 2019;39:90-7. [PMID: 30160363 DOI: 10.1111/liv.13950] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
13 Jan CF, Chang HC, Tantoh DM, Chen PH, Liu WH, Huang JY, Wu MC, Liaw YP. Duration-response association between exercise and HDL in both male and female Taiwanese adults aged 40 years and above. Oncotarget 2018;9:2120-7. [PMID: 29416758 DOI: 10.18632/oncotarget.23251] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
14 Tomic D, Kemp WW, Roberts SK. Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies. Eur J Gastroenterol Hepatol 2018;30:1103-15. [PMID: 30113367 DOI: 10.1097/MEG.0000000000001235] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
15 Lin H, Lee SS, Yu M, Chang T, Su C, Hu B, Chen Y, Huang C, Lai C, Lin J, Wu J. Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program: HEPATOLOGY, Month 2015. Hepatology 2015;61:1870-9. [DOI: 10.1002/hep.27742] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 6.4] [Reference Citation Analysis]
16 Chen PC, Kao WY, Cheng YL, Wang YJ, Hou MC, Wu JC, Su CW. The correlation between fatty liver disease and chronic kidney disease. J Formos Med Assoc. 2020;119:42-50. [PMID: 30876789 DOI: 10.1016/j.jfma.2019.02.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
17 Cheng YL, Wang YJ, Kao WY, Chen PH, Huo TI, Huang YH, Lan KH, Su CW, Chan WL, Lin HC, Lee FY, Wu JC. Inverse association between hepatitis B virus infection and fatty liver disease: a large-scale study in populations seeking for check-up. PLoS One. 2013;8:e72049. [PMID: 23991037 DOI: 10.1371/journal.pone.0072049] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 5.4] [Reference Citation Analysis]
18 Vespasiani-Gentilucci U, Gallo P, Piccinocchi G, Piccinocchi R, Schena E, Galati G, De Vincentis A, Dell'Unto C, Picardi A. Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age. Dig Liver Dis 2014;46:909-15. [PMID: 24953204 DOI: 10.1016/j.dld.2014.05.021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
19 Ooi GJ, Burton PR, Doyle L, Wentworth JM, Bhathal PS, Sikaris K, Cowley MA, Roberts SK, Kemp W, Earnest A, O’brien PE, Brown WA. Effects of Bariatric Surgery on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease. OBES SURG 2017;27:1533-42. [DOI: 10.1007/s11695-016-2482-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
20 Tanaka K, Hyogo H, Ono M, Takahashi H, Kitajima Y, Ono N, Eguchi T, Fujimoto K, Chayama K, Saibara T, Anzai K, Eguchi Y; Japan Study Group of Non-alcoholic Fatty Liver Disease (JSG-NAFLD). Upper limit of normal serum alanine aminotransferase levels in Japanese subjects. Hepatol Res 2014;44:1196-207. [PMID: 24372862 DOI: 10.1111/hepr.12293] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
21 Gallo P, De Vincentis A, Bandinelli S, Ferrucci L, Picardi A, Antonelli Incalzi R, Vespasiani-Gentilucci U. Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients. Aging Clin Exp Res 2021. [PMID: 34506007 DOI: 10.1007/s40520-021-01979-9] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Park JH, Choi J, Jun DW, Han SW, Yeo YH, Nguyen MH. Low Alanine Aminotransferase Cut-Off for Predicting Liver Outcomes; A Nationwide Population-Based Longitudinal Cohort Study. J Clin Med 2019;8:E1445. [PMID: 31514449 DOI: 10.3390/jcm8091445] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Varma A, Trudeau S, Zhou Y, Jafri SM, Krajenta R, Lamerato L, Brown K, Luzzi V, Lu M, Gordon SC. African Americans Demonstrate Significantly Lower Serum Alanine Aminotransferase Compared to Non-African Americans. J Racial Ethn Health Disparities 2020. [PMID: 33230736 DOI: 10.1007/s40615-020-00916-2] [Reference Citation Analysis]
24 Nakajima K, Yuno M, Tanaka K, Nakamura T. High Aspartate Aminotransferase/Alanine Aminotransferase Ratio May Be Associated with All-Cause Mortality in the Elderly: A Retrospective Cohort Study Using Artificial Intelligence and Conventional Analysis. Healthcare 2022;10:674. [DOI: 10.3390/healthcare10040674] [Reference Citation Analysis]
25 Nascimbeni F, Pais R, Bellentani S, Day CP, Ratziu V, Loria P, Lonardo A. From NAFLD in clinical practice to answers from guidelines. J Hepatol. 2013;59:859-871. [PMID: 23751754 DOI: 10.1016/j.jhep.2013.05.044] [Cited by in Crossref: 223] [Cited by in F6Publishing: 203] [Article Influence: 24.8] [Reference Citation Analysis]
26 Ooi GJ, Burton PR, Bayliss J, Raajendiran A, Earnest A, Laurie C, Kemp WW, Mclean CA, Roberts SK, Watt MJ, Brown WA. Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study. OBES SURG 2019;29:99-108. [DOI: 10.1007/s11695-018-3479-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
27 Wang Y, Wang M, Li H, Chen K, Zeng H, Bi X, Zhu Z, Jiao Y, Wang Y, Zhu J, Zhao H, Liu X, Dai C, Fan C, Zhao C, Guo D, Zhao H, Zhou J, Wang D, Wu Z, Zhao X, Cui W, Zhang X, Cai J, Chen W, Qu C. A male-ABCD algorithm for hepatocellular carcinoma risk prediction in HBsAg carriers. Chin J Cancer Res 2021;33:352-63. [PMID: 34321832 DOI: 10.21147/j.issn.1000-9604.2021.03.07] [Reference Citation Analysis]
28 Pacifico L, Ferraro F, Bonci E, Anania C, Romaggioli S, Chiesa C. Upper limit of normal for alanine aminotransferase: quo vadis? Clin Chim Acta. 2013;422:29-39. [PMID: 23566931 DOI: 10.1016/j.cca.2013.03.030] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
29 Wei H, Wu H, Yu W, Yan X, Zhang X. Shenfu decoction as adjuvant therapy for improving quality of life and hepatic dysfunction in patients with symptomatic chronic heart failure. J Ethnopharmacol 2015;169:347-55. [PMID: 25937255 DOI: 10.1016/j.jep.2015.04.016] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
30 Petroff D, Bätz O, Jedrysiak K, Kramer J, Berg T, Wiegand J. Age Dependence of Liver Enzymes: An Analysis of Over 1,300,000 Consecutive Blood Samples. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00089-6. [PMID: 33524594 DOI: 10.1016/j.cgh.2021.01.039] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Xu L, Lin K, Li SL. Factors associated with reverse change of serum ALT activity in patients with chronic hepatitis B. Shijie Huaren Xiaohua Zazhi 2018; 26(34): 1996-2001 [DOI: 10.11569/wcjd.v26.i34.1996] [Reference Citation Analysis]
32 Kao WY, Lin YF, Chang IW, Chen CL, Tang JH, Chang CC, Chang YJ, Wang W. Interleukin-2 receptor alpha as a biomarker for nonalcoholic fatty liver disease diagnosis. J Chin Med Assoc 2021;84:261-6. [PMID: 33306598 DOI: 10.1097/JCMA.0000000000000469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
33 Umehara T. Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: Cross-sectional study in U.S. adults. PLoS One 2018;13:e0197900. [PMID: 29897928 DOI: 10.1371/journal.pone.0197900] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
34 Yang BL, Wu WC, Fang KC, Wang YC, Huo TI, Huang YH, Yang HI, Su CW, Lin HC, Lee FY, Wu JC, Lee SD. External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan. PLoS One 2015;10:e0120443. [PMID: 25781622 DOI: 10.1371/journal.pone.0120443] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 7.1] [Reference Citation Analysis]
35 Cheng YL, Wang YJ, Lan KH, Huo TI, Huang YH, Su CW, Hsieh WY, Hou MC, Lin HC, Lee FY, Wu JC, Lee SD. Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease. Gastroenterol Res Pract 2017;2017:9279836. [PMID: 28194177 DOI: 10.1155/2017/9279836] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
36 Su C, Chau G, Hung H, Yeh Y, Lei H, Hsia C, Lai C, Lin H, Wu J. Impact of Steatosis on Prognosis of Patients with Early-Stage Hepatocellular Carcinoma After Hepatic Resection. Ann Surg Oncol 2015;22:2253-61. [DOI: 10.1245/s10434-014-4221-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
37 Kolahdoozan S, Mirminachi B, Sepanlou SG, Malekzadeh R, Merat S, Poustchi H. Upper Normal Limits of Serum Alanine Aminotransferase in Healthy Population: A Systematic Review. Middle East J Dig Dis 2020;12:194-205. [PMID: 33062225 DOI: 10.34172/mejdd.2020.182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Kao WY, Chang IW, Chen CL, Su CW, Fang SU, Tang JH, Chang CC, Chang YJ, Wang W. Fibroscan-Based Score to Predict Significant Liver Fibrosis in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease. Obes Surg 2020;30:1249-57. [PMID: 31953745 DOI: 10.1007/s11695-019-04192-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
39 Kao W, Su C, Fang S, Tang J, Chang C, Liu J. Determination of the predictive factors for significant liver fibrosis assessed through transient elastography. Adv Dig Med 2019;6:5-14. [DOI: 10.1002/aid2.13102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]